CDC-Authored Genomics and Precision Health Publications Database
Rare Diseases
Last data update: May 06, 2024. (Total: 5935 publications)
Query Trace: Duchenne Muscular Dystrophy[original query] |
---|
Seroprevalence of AAV neutralizing antibodies in males with Duchenne muscular dystrophy.
Verma S , Nwosu SN , Razdan R , Upadhyayula SR , Phan HC , Koroma AA , Leguizamo I , Correa NS , Kuipa M , Lee D , Vanderford TH , Gardner MR . Hum Gene Ther 2022 34 430-438 |
Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network.
Paramsothy P , Wang Y , Cai B , Conway KM , Johnson NE , Pandya S , Ciafaloni E , Mathews KD , Romitti PA , Howard JFJr , Riley C . Neuromuscul Disord 2022 32 (6) 468-476 |
Time to Diagnosis of Duchenne Muscular Dystrophy Remains Unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), 2000-2015.
Thomas S , Conway KM , Fapo O , Street N , Mathews KD , Mann J , Romitti PA , Soim A , Westfield C , Fox DJ , Ciafaloni E . Muscle Nerve 2022 66 (2) 193-197 |
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.
Birnkrant DJ , Bushby K , Bann CM , Apkon SD , Blackwell A , Brumbaugh D , Case LE , Clemens PR , Hadjiyannakis S , Pandya S , Street N , Tomezsko J , Wagner KR , Ward LM , Weber DR . Lancet Neurol 2018 17 (3) 251-267 |
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.
Birnkrant DJ , Bushby K , Bann CM , Alman BA , Apkon SD , Blackwell A , Case LE , Cripe L , Hadjiyannakis S , Olson AK , Sheehan DW , Bolen J , Weber DR , Ward LM . Lancet Neurol 2018 17 (4) 347-361 |
Public Health and Rare Diseases: Oxymoron No More.
Valdez R , Ouyang L , Bolen J . Prev Chronic Dis 2016 13 E05 |
Evidence-based path to newborn screening for Duchenne muscular dystrophy.
Mendell JR , Shilling C , Leslie ND , Flanigan KM , Al-Dahhak R , Gastier-Foster J , Kneile K , Dunn DM , Duval B , Aoyagi A , Hamil C , Mahmoud M , Roush K , Bird L , Rankin C , Lilly H , Street N , Chandrasekar R , Weiss RB . Ann Neurol 2012 71 (3) 304-13 |
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Bushby K , Finkel R , Birnkrant DJ , Case LE , Clemens PR , Cripe L , Kaul A , Kinnett K , McDonald C , Pandya S , Poysky J , Shapiro F , Tomezsko J , Constantin C , DMD Care Considerations Working Group . Lancet Neurol 2010 9 (1) 77-93 |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: